Pages that link to "Q808845"
Jump to navigation
Jump to search
The following pages link to ceftazidime (Q808845):
Displaying 50 items.
- staphylococcal infection (Q34879) (← links)
- World Health Organization Model List of Essential Medicines (Q37155) (← links)
- sepsis (Q183134) (← links)
- erysipelas (Q207092) (← links)
- urinary tract infection (Q221668) (← links)
- hyperthermia (Q242165) (← links)
- bacterial infectious disease (Q727028) (← links)
- melioidosis (Q963944) (← links)
- neutropenia (Q1435822) (← links)
- upper respiratory tract infection (Q2622199) (← links)
- bacterial meningitis (Q3678510) (← links)
- bacterial pneumonia (Q3776920) (← links)
- Escherichia coli infectious disease (Q4227886) (← links)
- infectious bone disease (Q6029216) (← links)
- Pseudomonas infection (Q7255052) (← links)
- Serratia infection (Q16935263) (← links)
- gram-negative bacterial infection (Q19597369) (← links)
- ceftazidime/avibactam (Q20973563) (← links)
- Anti-inflammatory effects of the antibiotics ceftazidime and tobramycin in porcine endotoxin shock: are they really anti-inflammatory? (Q24805461) (← links)
- Anti-inflammatory effects of the antibiotics ceftazidime and tobramycin in porcine endotoxin shock: are they really anti-inflammatory? Authors' response (Q24805486) (← links)
- Endotoxin neutralization and anti-inflammatory effects of tobramycin and ceftazidime in porcine endotoxin shock (Q24806164) (← links)
- Structures of ceftazidime and its transition-state analogue in complex with AmpC beta-lactamase: implications for resistance mutations and inhibitor design (Q27633777) (← links)
- Halving of mortality of severe melioidosis by ceftazidime (Q28257666) (← links)
- Exploring the role of a conserved class A residue in the Ω-Loop of KPC-2 β-lactamase: a mechanism for ceftazidime hydrolysis (Q28272040) (← links)
- Comparative in vitro study of the antimicrobial activity of ceftazidime against clinical isolates (Q28295653) (← links)
- A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients (Q28307297) (← links)
- Epitope analysis of aztreonam by antiaztreonam monoclonal antibodies and possible consequences in beta-lactams hypersensitivity (Q28316455) (← links)
- Ceftazidime encephalopathy: absence status and toxic hallucinations (Q28319796) (← links)
- Evaluation of the immunologic cross-reactivity of aztreonam in patients with cystic fibrosis who are allergic to penicillin and/or cephalosporin antibiotics (Q28328527) (← links)
- Neurotoxicity associated with ceftazidime therapy in geriatric patients with renal dysfunction (Q28333568) (← links)
- Sensitization to aztreonam and cross-reactivity with other beta-lactam antibiotics in high-risk patients with cystic fibrosis (Q28334722) (← links)
- Hallucinations in association with ceftazidime (Q28361059) (← links)
- Pharmacokinetics and therapeutic efficacy of imipenem, ceftazidime, and ceftriaxone in experimental meningitis due to an ampicillin- and chloramphenicol-resistant strain of Haemophilus influenzae type b (Q28366308) (← links)
- Ceftazidime nephrotoxicity in rats (Q28366454) (← links)
- Fatal encephalopathy induced by ceftazidime (Q28370956) (← links)
- Natural Variants of the KPC-2 Carbapenemase have Evolved Increased Catalytic Efficiency for Ceftazidime Hydrolysis at the Cost of Enzyme Stability (Q28547682) (← links)
- Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments (Q28550910) (← links)
- Vergleichende In vitro-Studie zur antimikrobiellen Aktivität von Ceftazidim gegen klinische Isolate (Q30050647) (← links)
- Comparison of ceftazidime with cefamandole for therapy of community-acquired pneumonia (Q30451309) (← links)
- Disposition and bioavailability of ceftazidime after intraperitoneal administration in patients receiving continuous ambulatory peritoneal dialysis (Q30469790) (← links)
- Amino acid sequence determinants of extended spectrum cephalosporin hydrolysis by the class C P99 beta-lactamase (Q30731622) (← links)
- Elucidation of Mechanisms of Ceftazidime Resistance among Clinical Isolates of Pseudomonas aeruginosa by Using Genomic Data (Q31073879) (← links)
- Single-daily ceftriaxone plus amikacin versus thrice-daily ceftazidime plus amikacin as empirical treatment of febrile neutropenia in children with cancer (Q31902665) (← links)
- Measurement and pharmacokinetic analysis of unbound ceftazidime in rat blood using microdialysis and microbore liquid chromatography. (Q32005808) (← links)
- Roles of amino acids 161 to 179 in the PSE-4 omega loop in substrate specificity and in resistance to ceftazidime (Q32012271) (← links)
- Rapid antibiotic drug monitoring: meropenem and ceftazidime determination in serum and bronchial secretions by high-performance liquid chromatography-integrated sample preparation. (Q32115163) (← links)
- Does high level production of SHV-type penicillinase confer resistance to ceftazidime in Enterobacteriaceae? (Q33225710) (← links)
- Comparison of lung tissue concentrations of nebulized ceftazidime in ventilated piglets: ultrasonic versus vibrating plate nebulizers (Q33342273) (← links)
- Changes in some hemostatic parameters in patients with infections treated with ceftazidime and latamoxef. (Q33412789) (← links)
- Comparison of the in vitro and in vivo susceptibilities of Burkholderia mallei to Ceftazidime and Levofloxacin. (Q33441941) (← links)